#Nimotuzumab; #head and neck cancer#Tata Memorial Hospital#Eris Lifesciences#study

adminJuly 31, 2024
0 15

Tata Memorial study finds Nimotuzumab significantly increases survival in head and neck cancer

Bangalore, July 30, 2024: A study conducted by Tata Memorial Hospital in Mumbai has shown that adding Nimotuzumab to…
Read More »